The role of suppressor T cells in regulation of immune responses

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 5, 2002, Pages 693-702

  McHugh, Rebecca S ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Allergy; Autoimmunity; CD4+CD25+ T cells; Chronic infection; Immunoregulation; Immunotherapy; Tolerance; Tumor immunity

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ALLERGY; ANIMAL MODEL; AUTOIMMUNITY; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0036857530     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.129339     Document Type: Article

References (78)

1. Nishizuka Y, Sakakura T. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969;166:753-5.
2. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Prevention of post-thymectomy autoimmune thyroiditis in mice. Lab Invest 1976;34:601-5.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunological self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25) - Breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases. J Immunol 1995;155:1151-64.
4. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4(+)CD25(+) T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212-8.
5. Thornton AM, Shevach EM. CD4(+)CD25(+) immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-96.
6. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-80.
7. Thornton AM, Shevach EM. Suppressor effector function of CD4(+)CD25(+) immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-90.
8. Piccirillo C, Shevach E. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-40.
9. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1003.
10. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
11. Stephens LA, Mason D. CD25 is a marker for CD4(+) thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25(+) and CD25(-) subpopulations. J Immunol 2000;165:3105-10.
12. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4(+)CD25(+) immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-40.
13. Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 2001;193:F41-5.
14. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4(+) T cells. J Exp Med 1996;183:2669-74.
15. Seddon B, Mason D. Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(-) cells and CD4(+)CD8(-) thymocytes. J Exp Med 1999;189:279-88.
16. Groux H, Ogarra A, Bigler M, Rouleau M, Antonenko S, deVries JE, et al. A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
17. Zhang X, Izikson L, Lui L, Weiner HL. Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J Immunol 2001;167:4245-53.
18. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-22.
19. Shevach EM. CD4+CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002;2:389-400.
20. Hara I, Takechi Y, Houghton AN. Implicating a role for immune recognition of self in tumor rejection - Passive-immunization against the brown locus protein. J Exp Med 1995;182:1609-14.
21. Geissler M, Mohr L, Weth R, Kohler G, Grimm CF, Krohne TU, et al. Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice. Gastroenterology 2001;121:931-9.
22. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo. J Exp Med 2000;192:1637-43.
23. Ludewig B, Ochsenbein AF, Odermatt B, Paulin D, Hengartner H, Zinkernagel RM. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med 2000;191:795-803.
24. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999;59:3128-33.
25. Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25(+)CD4(+) T cells: A common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-8.
26. Steitz J, Bruck J, Lenz J, Knop J, Tuting T. Depletion of CD25+CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon a-induced, CD8+ T-cell-dependent immune defense of B16 melanoma. Cancer Res 2001;61:8643-6.
27. Sutmuller RPM, van Duivenvoorde LM, van Elsas A, Schumacher TNM, Wildenberg ME, Allison JP, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-32.
28. Berendt MJ, North RJ. T-cell-mediated suppression of anti-timor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 1980;151:69-80.
29. North RJ. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 1982;155:1063-74.
30. Bursuker I, North RJ. Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T-cells from tumor-bearing donors. Cancer Immunol Immunother 1985;19:215-8.
31. Awwad M, North RJ. Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity. Cancer Immunol Immunother 1988;26:55-60.
32. Awwad M, North RJ. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphomide-resistant murine tumor: A consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res 1989;49:1649-54.
33. Taguchi O, Takahashi T. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol 1996;26:1608-12.
34. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, et al. Cutting Edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168:4272-6.
35. Taguchi O, Kontani K, Ikeda H, Kezuka T, Takeuchi M, Takahashi T. Tissue-specific suppressor T-cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 1994;82:365-9.
36. Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 1999;189:877-81.
37. McHugh RS, Shevach EM. Cutting edge: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002;168:5979-83.
38. Hall B, Jelbart M, Gurley K, Dorsch S. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985;162:1683-94.
39. Qin S, Cobbold SP, Pope H, Elliott D, Kioussis D, Davies J, et al. "Infectious" transplantation tolerance. Science 1993;259:974-7.
40. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998;16:619-44.
41. Mohler KM, Streilein JW. Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens. Transplantation 1989;47:625-33.
42. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-96.
43. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4 and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002;168:1080-6.
44. Sanchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002;168:2274-81.
45. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002;195:1641-6.
46. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001;193:1311-7.
47. Graca L, Thompson S, Lin C-Y, Adams E, Cobbold SP, Waldmann H. Both CD4+CD25+ and CD4+CD25- regulatory cells mediate dominant transplant tolerance. J Immunol 2002;168:5558-65.
48. Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun 2001;16:115-23.
49. McHugh R, Shevach E, Thornton A. Control of organ-specific autoimmunity by immunoregulatory CD4+CD25+ T cells. Microbes Infect 2001;3:919-27.
50. Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002;168:1069-79.
51. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, et al. CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-23.
52. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol 2002;3:33-41.
53. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent Type 1-like regulatory T cells. J Exp Med 2002;196:247-53.
54. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious Tolerance: Human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med 2002;196:255-60.
55. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1a,25-Dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001;167:1945-53.
56. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8:625-9.
57. Powrie F, Correaoliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RB(High) and CD45RB(Low) CD4(+) T-cells are important for the balance between protective and pathogenic cell-mediated-immunity. J Exp Med 1994;179:589-600.
58. Aranda R, Sydora B, McAllister P, Binder S, Yang H, Targan S, et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol 1997;158:3464-73.
59. Coutinho A, Hori S, Carvalho TL, Caramalho I, Demengeot J. Regulatory T cells: The physiology of autoreactivity in dominant tolerance and "quality control" of immune responses. Immunol Rev 2001;182:89-98.
60. Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002;32:1282-91.
61. Roths JB, Sidman CL. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+, but not CD8+, T cells into severe combined immunodeficiency mice. J Clin Invest 1992;90:673-8.
62. Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 2000;6:1327-9.
63. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Ann Rev Med 2002;53:557-93.
64. Bogdan C, Gessner A, Solbach W, Rollinghoff M. Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol 1996;8:517-25.
65. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001;194:1497-506.
66. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ immunoregulatory T lymphocytes control Leishmania major persistence and the development of concomitant immunity. Nature 2002. In press.
67. Iwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Nat Acad Sci U S A 2001;98:9226-30.
68. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J, et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected patients. J Infect Dis 2002;185:720-7.
69. McGuirk P, McCann C, Mills KHG. Pathogen-specific T regulatory 1 cells induced in the respitory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper Type 1 responses by Bordetella pertussis. J Exp Med 2002;195:221-31.
70. Wills-Karp M. IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 2001;107:9-18.
71. Oettgen HC, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001;107:429-40.
72. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
73. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hypersensitivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
74. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001;108:594-601.
75. Suri-Payer E, Amar AZ, McHugh R, Natarajan K, Margulies DH, Shevach EM. Post-thymectomy autoimmune gastritis: Fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol 1999;29:669-77.
76. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response n vivo. J Immunol 2000;165:4848-53.
77. Suto A, Nakajima H, Kagami S-I, Suzuki K, Saito Y, Iwamoto I. Role of CD4+CD25+ regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med 2001;164:680-7.
78. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-42.